Institutional Ownership
Praxis Precision Medicines I
CUSIP 74006W207COM NEWPRAXQ1 2026
13D / 13G Filings
55
Schedule 13D/13G on record
Beneficial Filers
23
Distinct reporting persons
Largest Stake
12.4%
Max % of class reported
Institutional Holders
280
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
55 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Perceptive Advisors LLC | 13G/A | 7.2% | 2.00M | SEC |
| 2 | Feb 17, 2026 | Orbis Investment Management Ltd | 13G | 5.0% | 1.26M | SEC |
| 3 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 6.1% | 1.57M | SEC |
| 4 | Feb 12, 2026 | Adage Capital Management, L.P. | 13G/A | 3.8% | 965.3K | SEC |
| 5 | Feb 5, 2026 | Fmr LLC | 13G | 5.4% | 1.35M | SEC |
| 6 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 12.3% | 2.76M | SEC |
| 7 | Nov 14, 2025 | Cormorant Asset Management, LP | 13G/A | 4.0% | 1.00M | SEC |
| 8 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 9.6% | 2.07M | SEC |
| 9 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 4.8% | 1.00M | SEC |
| 10 | Nov 7, 2025 | Morgan Stanley | 13G/A | 2.9% | 618.0K | SEC |
45 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Praxis Precision Medicines I.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 3.46M | $1.11B |
| 2 | Orbis Allan Gray Ltd | 2.47M | $796.61M |
| 3 | Blackrock, Inc. | 2.32M | $749.07M |
| 4 | Fmr LLC | 2.16M | $696.23M |
| 5 | Perceptive Advisors LLC | 2.04M | $655.97M |
| 6 | Baker Bros. Advisors LP | 1.75M | $564.86M |
| 7 | Deerfield Management Company, L.P. | 963.4K | $310.38M |
| 8 | Driehaus Capital Management LLC | 949.2K | $305.83M |
| 9 | Cormorant Asset Management, LP | 885.5K | $285.30M |
| 10 | State Street Corp | 884.2K | $284.89M |